Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body

Molecular Vision

Volumn 16, Issue , 2010, Pages 130-136

  Izuta, Hiroshi ^a   Matsunaga, Nozomu ^a   Shimazawa, Masamitsu ^a   Sugiyama, Tetsuya ^b   Ikeda, Tsunehiko ^b   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CUPRIC ION; LIPID PEROXIDE; VASCULOTROPIN; ANTIOXIDANT; LYSINE; N(EPSILON) HEXANOYLLYSINE; N(EPSILON)-HEXANOYLLYSINE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETINA MACULA HOLE; RISK FACTOR; VITREOUS BODY; BLOOD; METABOLISM; MIDDLE AGED; PATHOLOGY; RETINA TEAR;

ANTIOXIDANTS; DIABETIC RETINOPATHY; FEMALE; HUMANS; LYSINE; MALE; MIDDLE AGED; OXIDATIVE STRESS; RETINAL PERFORATIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 77949326673     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246:1309-1312. [PMID: 2479987]
2. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominantnegative Flk-1 mutant. Nature 1994; 367:576-579. [PMID: 8107827]
3. Sone H, Kawakami Y, Okuda Y, Kondo S, Hanatani M, Suzuki H, Yamashita K. Vascular endothelial growth factor is induced by long-term high glucose concentration and upregulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 1996; 221:193-198. [PMID: 8660335]
4. Aiello LP. Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 1997; 8:19-31. [PMID: 10168890]
5. Funatsu H, Yamashita H, Noma H, Mochizuki H, Mimura T, Ikeda T, Hori S. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin. Invest Ophthalmol Vis Sci 2003; 44:1042-1047. [PMID: 12601027]
6. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999; 48:1899-1906. [PMID: 10512352]
7. Ceriello A, Quatraro A, Giugliano D. New insights on nonenzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 1992; 9:297-299. [PMID: 1576819]
8. Collier A, Small M. The role of the polyol pathway in diabetes mellitus. Br J Hosp Med 1991; 45:38-40. [PMID: 1901236]
9. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 2008; 9:315-327. [PMID: 18654858]
10. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008; 57:1446-1454. [PMID: 18511445]
11. Jaswal S, Mehta HC, Sood AK, Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003; 338:123-129. [PMID: 14637276]
12. Kato Y, Mori Y, Makino Y, Morimitsu Y, Hiroi S, Ishikawa T, Osawa T. Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 1999; 274:20406-20414. [PMID: 10400665]
13. Naito M, Wu X, Nomura H, Kodama M, Kato Y, Kato Y, Osawa T. The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb 2002; 9:243-250. [PMID: 12409634]
14. Straface E, Matarrese P, Gambardella L, Vona R, Sgadari A, Silveri MC, Malorni W. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett 2005; 579:2759-2766. [PMID: 15907478]
15. de Martino M, Chiarelli F, Moriondo M, Torello M, Azzari C, Galli L. Restored antioxidant capacity parallels the immunologic and virologic improvement in children with perinatal human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Immunol 2001; 100:82-86. [PMID: 11414748]
16. Polak M, Zagorski Z. Lipid peroxidation in diabetic retinopathy. Ann Univ Mariae Curie Sklodowska [Med] 2004; 59:434-437. [PMID: 16146026]
17. Minato K, Gono M, Yamaguchi H, Kato Y, Osawa T. Accumulation of Nepsilon-(Hexanoyl)lysine, an oxidative stress biomarker, in rice seeds during storage. Biosci Biotechnol Biochem 2005; 69:1806-1810. [PMID: 16195608]
18. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996; 98:1667-1675. [PMID: 8833917]
19. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 2002; 277:3101-3108. [PMID: 11719508]
20. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002; 91:1160-1167. [PMID: 12480817]
21. Verdejo C, Marco P, Renau-Piqueras J, Pinazo-Duran MD. Lipid peroxidation in proliferative vitreoretinopathies. Eye 1999; 13:183-188. [PMID: 10450379]
22. Cicik E, Tekin H, Akar S, Ekmekçi OB, Donma O, Koldaş L, Ozkan S. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthalmic Res 2003; 35:251-255. [PMID: 12920337]
23. Izuta H, Chikaraishi Y, Adachi T, Shimazawa M, Sugiyama T, Ikeda T, Hara H. Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. Mol Vis 2009; 15:2663-2672.
24. Ottaviano FG, Handy DE, Loscalzo J. Redox regulation in the extracellular environment. Circ J 2008; 72:1-16. [PMID: 18159092]
25. Srivatsan R, Das S, Gadde R, Manoj-Kumar K, Taduri S, Rao N, Ramesh B, Baharani A, Shah K, Kamireddy SC, Priyatham G, Balakumaran TA, Balakumaran SS, Kamath A, Rao A. Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med 2009; 12:121-127. [PMID: 19249880]
26. Kakisaka Y, Nakashima T, Sumida Y, Yoh T, Nakamura H, Yodoi J, Senmaru H. Elevation of serum thioredoxin levels in patients with type 2 diabetes. Horm Metab Res 2002; 34:160-164. [PMID: 11972307]
27. Yoh K, Hirayama A, Ishizaki K, Yamada A, Takeuchi M, Yamagishi S, Morito N, Nakano T, Ojima M, Shimohata H, Itoh K, Takahashi S, Yamamoto M. Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells 2008; 13:1159-1170. [PMID: 19090810]
28. He X, Kan H, Cai L, Ma Q. Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. J Mol Cell Cardiol 2009; 46:47-58. [PMID: 19007787]